Gilead Email Format

Biotechnology Research
10,001-25,000 employees
Foster City, CA, USA

Gilead is a biopharmaceutical company that discovers, develops, and commercializes innovative medicines in virology, oncology, and other therapeutic areas worldwide.

Find contacts at Gilead

Search our verified sources for decision-makers, emails, and titles.

Start searching
VERIFIED BY CLAY

first.last@gilead.com

Company Overview

Industry
Biotechnology Research
Founded
1987
Headquarters
Foster City, CA, USA
Revenue
$25B-$50B
FUNDING Stage
Public
Key Executives
Daniel O'Day (Chairman and Chief Executive Officer, Gilead Sciences), Andrew Dickinson (Chief Financial Officer), Johanna Mercier (Chief Commercial & Corporate Affairs Officer)

Tech Stack

AWS

Cloud

Signup

to know

Signup

to know

Signup

to know

Key Executives

Chief Executive Officer

Find the current person →

Chief Finance Officer

Find the current person →

Chief Operating Officer

Find the current person →

Chief Technology Officer

Find the current person →

Chief Marketing Officer

Find the current person →

Chairman

Find the current person →

4.9/5 on G2
40K+ GTM professionals
SOC 2 Type II certified

Frequently Asked Questions

What is the email format of Gilead?

Gilead uses the first.last format on gilead.com, so Jane Smith would be jane.smith@gilead.com.

What are Gilead's three main therapeutic areas?

Gilead focuses its research and medicines across three therapeutic areas: Virology, Oncology, and Inflammation. Its Virology work includes well-known HIV and hepatitis treatments, while its Oncology platform is advanced through its Kite subsidiary and cell therapy programs.

How does Kite, a Gilead company, fit into Gilead's oncology strategy?

Kite is Gilead's oncology-focused subsidiary, headquartered in Santa Monica, California. Founded in 2009 and acquired by Gilead in 2017, Kite specializes in CAR T-cell therapies and is a core part of Gilead's push to develop curative treatments for cancer.

What is Gilead's lenacapavir and why is it significant for HIV prevention?

Lenacapavir, sold by Gilead as Sunlenca, is a first-in-class HIV capsid inhibitor administered just twice yearly. Clinical trials showed it delivered superior HIV prevention compared to once-daily oral options, making it a notable advance in long-acting prevention and treatment.

Where is Gilead headquartered and how large is the company?

Gilead is headquartered in Foster City, California and employs approximately 14,613 people globally. You can use Clay to find and verify contact details for specific Gilead employees across its worldwide offices.

Share Article

Get access to more people and company data using Clay

Leverage the power of 100+ data providers for industry-leading data coverage & quality.

4.9 rating

More Articles